Medicinal Chemistry: Lead optimisation and lead discovery
Date : 1 - 4 February 2009
Venue : Playa del Carmen, Mexico
Website: http://www.zingconferences.com/
Brief Summary: This conference will discuss medicinal chemistry strategies and successes together with emerging technologies for discovering leads, and will draw on expertise from an impressive line-up of renowned scientists from industry and academia.
2009 Drug Discovery for Neurodegeneration presented by the Alzheimer's Drug Discovery Foundation
Date : 2 - 3 February 2009
Venue : Washington DC, DC, United States
Website: http://www.alzdiscovery.org
logP2009 - PhysChem and ADMET Profiling in Drug ResearchDate : 8 - 11 February, 2009
Venue : ETH Zurich, Switzerland
Email : info-LogP2009@pharma.ethz.ch
Website: http://www.pharma.ethz.ch
Brief Summary: The LogP2009 Symposium offers various opportunities for learning and exchange, including lectures, oral short communications, posters, a commercial exhibition, a satellite meeting and social events. The focus will be on in vitro and in silico techniques to predict and optimise the pharmacokinetic (ADMET*) behaviour of lead and drug candidates. The main topics will be PhysChem (Ionisation, Solubility, Partitioning, and Permeation) including a debate on "Membrane Permeation Mechanisms", Absorption, Distribution and Excretion, with a strong focus on transporter proteins, metabolism and toxicity and in a satellite event Perspectives in P-Glycoprotein Research - a Focus on New Assay Technologies".
First International conference: Modern Mucosal Vaccines Adjuvants and Microbicides
Date : 2 - 3 December, 2008
Venue : The Cumberland, London
Website: http://www.ftconferences.com
Brief Summary: The Financial Times Global Pharmaceutical and Biotechnology Conference will explore how fully understanding, harnessing and exploiting the underlying industry trends of convergence, collaboration and customer orientation can lead to new avenues for innovation and exiting new opportunities for revenue growth and profitability.
5th Nutraceutical Summit
Date :19 – 21 February, 2009
Venue : Mumbai, India
Website: http://www.nutraceuticalsummit.in/
Brief Summary: The Nutraceutical Summit is today recognised as the most authoritative forum of India on Nutraceuticals, Functional Foods and Dietary Supplements. The event is supported by the premier scientific bodies of India, CSIR and CFTRI and organised by MM Activ Sci-tech Communication Co. in association with leading associations like HADSA, IDMA, ADMA, OPPI, Pharmexcil and IDA.
Even though the Indian nutraceutical market is in a nascent stage, it is growing at a faster pace. Seeing the growth in world nutraceutical market and potential for India, many multinational and Indian pharmaceutical firms are entering in this arena. Also, these companies are introducing nutraceuticals as supplements to their main products in the therapeutic segments. FMCG firms are also venturing into this segment.
Imaging and Drug Development (C1)
Date :22 - 26 February 2009
Venue : Copper Mountain, Colorado, United States
Website:http://www.keystonesymposia.org/
Brief Summary: The objective of this conference is to bring together scientists within the PET molecular imaging community with expertise in imaging systems analytical tools and drug discovery.
Drug Discovery Latin America
Date :26- 27 February, 2013
Venue : Berlin, Germany
Email :paul.raggett@selectbiosciences.com
Brief Summary: The purpose of this meeting is to review the status of drug discovery activities in Latin America and to assist its future development. Business and research leaders from both developed markets and BRIC countries will bring their knowledge and experience to share. Participants will be encouraged to network and explore partnering opportunities. Specific topics will include but are not limited to Tropical Disease Drug Development, Small Molecule and Natural Products Screening, Drug Development in Academic Institutes, Partnering Opportunities in Emerging Markets.
Protein Purification: Principles and Practice
Date : 15- 20 March, 2009
Venue :Rutgers University, Lipman Hall, New Brunswick, New Jersey, USA
Website:http://www.rci.rutgers.edu/
E-Mail:rward@rci.rutgers.edu
Brief Summary: This five and one half day laboratory course covers a wide variety of conventional methods for protein isolation, purification, and characterization. The course format integrates hands-on laboratory exercises with classroom lectures, demonstrations, study breaks, and short take-home assignments. This course uses the remarkable Green-Fluorescent Protein (GFP), a novel marker for gene expression, as the source material. While this is a general course applicable to all proteins, we use GFP as a highly effective visual teaching tool. A special feature of the course is that all laboratory work will be performed on the same starting sample (Aequorea GFP or recombinant GFP), which will be purified from an exceedingly crude form (starting with tissue or bacterial cell extraction) to near homogeneity as judged by high performance liquid chromatography (HPLC), SDS gel electrophoresis, isoelectric focusing, and western blotting. This feature provides a continuity of purpose, integrating dozens of preparative and analytical protein techniques in a way that few competing courses can match.
Interphex 2009
Date :17- 19 March, 2009
Venue :Jacob K. Javits Center, New York
Email:cstrachan@reedexpo.com
Website:http://www.interphex.com
Brief Summary: INTERPHEX is the only Life Sciences event that represents a true cross-section of the pharmaceutical and biopharmaceutical industries. Industry-leading professionals worldwide make INTERPHEX the industry's annual focal point for driving change and efficiencies for the global pharmaceutical and biopharmaceutical market. This year, INTERPHEX has partnered with BIOTECHNICA, the leading biotechnology show in Europe, to feature BIOTECHNICA AMERICA making INTERPHEX the most comprehensive annual gathering in the life sciences industry.
PharmaMedDevice 2009
Date : 17-19 March, 2009
Venue: Jacob K. Javits Center, New York
E-Mail:inquiry@pharmameddevice.com
Website:http://www.pharmamedevice.com
Brief Summary: PharmaMedDevice, the first event to focus on the convergence of the medical device, pharmaceutical, and biologic industries as the future of combination products and drug delivery technology continue to evolve for 2008. This event is the first of its kind to address the needs of the combination products market and the exciting innovations taking place in drug delivery technology and healthcare today.
Antibodies as Drugs (X7)
Date :27 March - 1 April 2009
Venue : Whistler, British Columbia, Canada
Website :http://www.keystonesymposia.org/9x7
Brief Summary: This meeting will bring together experts from academia and industry to discuss the current state of antibody therapeutics, their mechanism of action in a range of medical indications, and novel approaches to improving manufacturing.
CBI’s 4th Annual Bio/Pharmaceutical Market Research Summit
Date : 13 – 14 April, 2009
Venue : Philadelphia, PA
Website:http://cbinet.com
E-Mail:cbireg@cbinet.com
Brief Summary: This annual summit continues to provide a platform for industry executives to network and discuss the evolution of market research within the bio/pharmaceutical industry. The following areas being researched for 2009 includes pricing and reimbursement, data access, restrictions and privacy issues, federal, state and local regulations, patient compliance, social networking, research innovation, business analytics, forecasting, market research ROI.
PDA 2009 Annual Meeting
Date : 20-24 April , 2009
Venue : Las Vegas, Nevada, USA
E-Mail:brown@pda.org
Website:http://www.pda.org
Brief Summary: PDA is currently seeking scientific abstracts for presentation at the PDA 2009 Annual Meeting, which will explore an area of immense importance to our industry - the current and future impact of computerization and automation. Few could argue that the microchip has and will continue to revolutionize the pharmaceutical and biopharmaceutical industry. Solved an unusually difficult technical problem by using computer systems, Developed an efficiency or quality improvement idea, Introduced a novel way of using computers and automation to improve process reliability or consistency, Managed process development data with unique software applications, Introduced new ways to automate Quality Assurance processes.
2nd world congress of Total Intravenous Anesthesia – TCI
Date : April 21, 2009 - April 25, 2009
Venue : Berlin
E-Mail: calendar@kenes.com
Website:http://www.kenes.com/tiva-tci/
Brief Summary: The 2nd World Congress of Total Intravenous Anesthesia TCI – (TIVA-TCI, Berlin 2009) is an International forum to coordinate, facilitate and provide high quality and educational presentations in this emerging area of anesthetic practice promoting new techniques for routine anesthesia as well as for the rapidly evolving area of conscious sedation. The congress aims to promote the highest quality of education for those involved with all drugs administered intravenously, and assist the introduction of new techniques into the standard curricula and examination systems of individual countries.
MEDTEC France
Date : 22 - 23 April, 2009
Venue : Parc des Expositions Metropolis, Besançon, France
E-Mail:fabienne.valambras@cancom.com
Website: www.medtecfrance.com
New Drugs in Cardiovascular Research
Date: 7- 9 May, 2009
Venue: Deutsches Hygiene Museum, Germany
E mail: aperner@intercom.de
Website: www.bps.ac.uk
Brief Summary: Cardiovascular pharmacology has made significant progress during recent years to identify new cellular targets for pharmacological interventions and to design new drugs for improved clinical treatment. The conference will focus both and clinical pharmacology, have significantly contributed to the success, eventually resulting in improved treatment strategies. For cardiovascular diseases. The conference comprises 3 plenary lectures,12 symposia or oral sessions, 100 posters. This joint meeting of the German Societies for Pharmacology and Clinical Pharmacology and the British Pharmacological Society will address this issue focussing in particular on basic cardiovascular research and its translation into clinical development.
|
